Retinal Microvasculature in Schizophrenia

• Published in: Eye and brain Vol. 13; pp. 205 - 217
• Main Authors: Silverstein, Steven M, Lai, Adriann, Green, Kyle M, Crosta, Christen, Fradkin, Samantha I, Ramchandran, Rajeev S
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01-01-2021; Taylor & Francis Ltd; Dove; Dove Medical Press
• Subjects: Age; arteriole; Diabetic retinopathy; Disease; Hospitalization; Nervous system diseases; Neurophysiology; oct angiography (octa); Original Research; Patients; Psychosis; Retina; Schizophrenia; venule; venule; OCT angiography; schizophrenia; OCTA; retina; arteriole
• ISSN: 1179-2744; 1179-2744
• DOI: 10.2147/EB.S317186

Schizophrenia is associated with alterations in neural structure and function of the retina that are similar to changes seen in the retina and brain in multiple neurodegenerative disorders. Preliminary evidence suggests that retinal microvasculature may also be compromised in schizophrenia. The goal of this study was to determine, using optical coherence tomography angiography (OCTA), whether 1) schizophrenia is associated with alterations in retinal microvasculature density; and 2) microvasculature reductions are associated with retinal neural layer thinning and performance on a measure of verbal IQ.
Twenty-eight outpatients with schizophrenia or schizoaffective disorder and 37 psychiatrically healthy control subjects completed OCT and OCTA exams, and the Wechsler Test of Adult Reading.
Schizophrenia patients were characterized by retinal microvasculature density reductions, and enlarged foveal avascular zones, in both eyes. These microvascular abnormalities were generally associated with thinning of retinal neural (macular and peripapillary nerve fiber layer) tissue (but the data were stronger for the left than the right eye) and lower scores on a proxy measure of verbal IQ. First- and later-episode patients did not differ significantly on OCTA findings.
The retinal microvasculature impairments seen in schizophrenia appear to be a biomarker of overall brain health, as is the case for multiple neurological conditions. Additional research is needed, however, to clarify contributions of social disadvantage and medical comorbidities to the findings.